SCHEMBL21362431

SCHEMBL21362431

CC(C)(C=O)c1ccc(C(=O)c2ccc(F)cc2)c(Br)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.40
ATM Q13315 1/20 0.39
GAA P10253 2/20 0.36
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35
HDAC3 O15379 2/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
LTA4H P09960 1/20 0.35
RXRA P19793 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362668 0.87 MAPT (0.44) TDP1GAAHDAC1HDAC6RXRA
SCHEMBL11860220 0.78 LTA4H (0.46) LTA4HRXRARAB9ASMN1; SMN2MEN1
SCHEMBL20157547 0.76 MAPT (0.50) TDP1RXRASMN1; SMN2NPC1MAPT
SCHEMBL20157523 0.74 CES2 (0.39) ATMGAAHDAC3HDAC1HDAC2
SCHEMBL20158052 0.74 LMNA (0.39) TDP1ATMHDAC3HDAC1HDAC2
SCHEMBL20157317 0.74 NPC1 (0.58) GAARAB9ASMN1; SMN2MEN1NPC1
SCHEMBL20157516 0.72 ALDH1A1 (0.48) TDP1GAARAB9ASMN1; SMN2MEN1
SCHEMBL21351910 0.72 LTC4S (0.38) TDP1ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL603094 0.72 VCP (0.38) TDP1ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL3597584 0.72 TP53 (0.54) ATMLTA4HSMN1; SMN2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed